AMERISE BIOSCIENCES LIMITED (AMERISE.BO)

INR 1.15

(4.55%)

Annual Income Statements

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 359 Thousand - 90.07 Million - - 11.8 Million
Cost of Revenue 1.82 Million - 89.67 Million - - 11.7 Million
Gross Profit -1.46 Million - 402.3 Thousand - - 100 Thousand
Operating Expenses 1.81 Million 1.27 Million 601.34 Thousand 1.67 Million 1.49 Million 58.88 Thousand
Selling, General and Administrative Expenses 1.81 Million 805 Thousand 601.34 Thousand 1.67 Million 1.48 Million 58.88 Thousand
Research and Development Expenses - - - - - -
Other Expenses - -471 Thousand - - -7990.00 -
Cost and Expenses 1.82 Million 1.27 Million 90.27 Million 1.67 Million 1.49 Million 11.75 Million
Operating Income -1.46 Million -1.27 Million -199.04 Thousand -1.67 Million -1.49 Million 41.12 Thousand
Interest Expense - 1000.00 3632.00 2065.00 3341.00 -
Income Tax Expense -167.89 Thousand -228.48 Thousand -236.55 Thousand -206.29 Thousand -171.86 Thousand -161.14 Thousand
Earnings before Tax -1.46 Million -1.18 Million 5.49 Million -3.37 Million -1.49 Million 41.12 Thousand
Net Income -1.46 Million -1.18 Million 5.49 Million -3.37 Million -1.49 Million 41.12 Thousand
Earnings Per Share Basic -0.02 -0.02 0.08 -0.05 -0.02 0.00
Earnings Per Share Diluted -0.02 -0.02 0.08 -0.05 -0.02 0.00
Weighted Average Shares Outstanding 66.06 Million 66.06 Million 66.06 Million 66.06 Million 66.06 Million 66.06 Million
Weighted Average Shares Outstanding (Diluted) 66.06 Million 66.06 Million 66.06 Million 66.06 Million 66.06 Million 66.06 Million
Gross Margin -4.07 - 0.00 - - 0.01
EBIT Margin -4.07 - -0.00 - - 0.00
Profit Margin -4.07 - 0.06 - - 0.00
EBITDA -1.46 Million -1.27 Million 5.49 Million -3.36 Million -1.48 Million 41.12 Thousand
Earnings Before Tax Margin -4.07 - -0.00 - - 0.00

Income Statement Charts